European Heart Journal Advance Access originally published online on April 28, 2005
European Heart Journal 2005 26(15):1488-1493; doi:10.1093/eurheartj/ehi288
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Five year clinical effect of coronary stenting and coronary artery bypass grafting in renal insufficient patients with multivessel coronary artery disease: insights from ARTS trial
1Thoraxcenter, Erasmus Medical Center, Rotterdam, The Netherlands
2Instituto Dante Pazzanese de Cardiologia, Sao Paulo, Brazil
3Hospital do Coracao, Sao Paulo, Brazil
4Catharina Ziekenhuis, Eindhoven, The Netherlands
5The Queen Elisabeth Hospital, Birmingham, UK
6Cardialysis, Rotterdam, The Netherlands
7University Klinik für Herzchirurgie, Salzburg, Austria
Received 2 November 2004; revised 20 February 2005; accepted 24 March 2005; online publish-ahead-of-print 28 April 2005.
* Corresponding author. Tel: +31 10 4635269; fax: +31 10 4639154. E-mail address: p.w.j.c.serruys{at}erasmusmc.nl
See page 1456 for the editorial comment on this article (doi:10.1093/eurheartj/ehi332)
Aims To compare coronary stent implantation and bypass surgery for multivessel coronary disease in patients with renal insufficiency.
Methods and results In the ARTS trial, 142 moderate renal insufficient patients (Ccr<60 mL/min) with multivessel coronary disease were randomly assigned to stent implantation (n=69) or CABG (n=73). At 5 years, there was no significant difference between the two groups in terms of mortality (14.5% in the stent group vs. 12.3% in the CABG group, P=0.81), or combined endpoint of death, cerebrovascular accident (CVA), or myocardial infarction (MI) (30.4% in the stent group vs. 23.3% in the CABG group, P=0.35). Among patients who survived without CVA or MI, 18.8% in the stent group underwent a second revascularization procedure when compared with 8.2% in the surgery group (P=0.08). The event-free survival at 5 years was 50.7% in the stent group and 68.5% in the surgery group (P=0.04).
Conclusion At 5 years, the differences in mortality and combined incidence of death, CVA, and MI between coronary stenting and surgery did not reach statistically significant level. However, the occurrence of MACCE in the stent group was higher than in the CABG group, mainly driven by the higher incidence of repeat revascularization in the stent group.
Key Words: Stent Coronary artery bypass Renal insufficiency
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Revascularization in patients with chronic kidney disease: the state of the ARTS
- Bertram Pitt
EHJ 2005 26: 1456-1457.[Extract] [FREE Full Text]
This article has been cited by other articles:
![]() |
A. Hakeem, S. Bhatti, K. S. Dillie, J. R. Cook, Z. Samad, M. D. Roth-Cline, and S. M. Chang Predictive Value of Myocardial Perfusion Single-Photon Emission Computed Tomography and the Impact of Renal Function on Cardiac Death Circulation, December 9, 2008; 118(24): 2540 - 2549. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.F. M. Bechtel, C. Detter, T. Fischlein, T. Krabatsch, B. R. Osswald, F.-C. Riess, F. Scholz, M. Schonburg, C. Stamm, H.-H. Sievers, et al. Cardiac Surgery in Patients on Dialysis: Decreased 30-Day Mortality, Unchanged Overall Survival Ann. Thorac. Surg., January 1, 2008; 85(1): 147 - 153. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Bravata, A. L. Gienger, K. M. McDonald, V. Sundaram, M. V. Perez, R. Varghese, J. R. Kapoor, R. Ardehali, D. K. Owens, and M. A. Hlatky Systematic Review: The Comparative Effectiveness of Percutaneous Coronary Interventions and Coronary Artery Bypass Graft Surgery Ann Intern Med, November 20, 2007; 147(10): 703 - 716. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. M. Holzhey, S. Jacobs, M. Mochalski, T. Walther, H. Thiele, F. W. Mohr, and V. Falk Seven-Year Follow-up After Minimally Invasive Direct Coronary Artery Bypass: Experience With More Than 1300 Patients Ann. Thorac. Surg., January 1, 2007; 83(1): 108 - 114. [Abstract] [Full Text] [PDF] |
||||
![]() |
N.C. Edwards, R.P. Steeds, C.J. Ferro, and J.N. Townend The treatment of coronary artery disease in patients with chronic kidney disease QJM, November 1, 2006; 99(11): 723 - 736. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. Pitt Revascularization in patients with chronic kidney disease: the state of the ARTS Eur. Heart J., August 1, 2005; 26(15): 1456 - 1457. [Full Text] [PDF] |
||||




